Go Pro

UnitedHealth Group (UNH) Competitors

UnitedHealth Group logo
$420.35 -5.01 (-1.18%)
As of 10:16 AM Eastern
This is a fair market value price provided by Massive. Learn more.

UNH vs. ALKS, MEDP, CI, CNC, and CVS

Should you buy UnitedHealth Group stock or one of its competitors? MarketBeat compares UnitedHealth Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with UnitedHealth Group include Alkermes (ALKS), Medpace (MEDP), Cigna Group (CI), Centene (CNC), and CVS Health (CVS). These companies are all part of the "medical" sector.

How does UnitedHealth Group compare to Alkermes?

Alkermes (NASDAQ:ALKS) and UnitedHealth Group (NYSE:UNH) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership.

UnitedHealth Group has higher revenue and earnings than Alkermes. UnitedHealth Group is trading at a lower price-to-earnings ratio than Alkermes, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alkermes$1.48B6.09$241.66M$0.9059.94
UnitedHealth Group$447.57B0.85$12.06B$13.2431.61

95.2% of Alkermes shares are owned by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are owned by institutional investors. 4.6% of Alkermes shares are owned by company insiders. Comparatively, 0.3% of UnitedHealth Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Alkermes has a net margin of 9.78% compared to UnitedHealth Group's net margin of 2.68%. UnitedHealth Group's return on equity of 14.65% beat Alkermes' return on equity.

Company Net Margins Return on Equity Return on Assets
Alkermes9.78% 9.26% 5.66%
UnitedHealth Group 2.68%14.65%4.77%

In the previous week, UnitedHealth Group had 50 more articles in the media than Alkermes. MarketBeat recorded 57 mentions for UnitedHealth Group and 7 mentions for Alkermes. UnitedHealth Group's average media sentiment score of 0.91 beat Alkermes' score of 0.57 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alkermes
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
UnitedHealth Group
38 Very Positive mention(s)
3 Positive mention(s)
10 Neutral mention(s)
4 Negative mention(s)
2 Very Negative mention(s)
Positive

Alkermes has a beta of 0.34, suggesting that its share price is 66% less volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market.

Alkermes currently has a consensus target price of $49.63, suggesting a potential downside of 8.01%. UnitedHealth Group has a consensus target price of $411.42, suggesting a potential downside of 1.69%. Given UnitedHealth Group's stronger consensus rating and higher possible upside, analysts clearly believe UnitedHealth Group is more favorable than Alkermes.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alkermes
1 Sell rating(s)
4 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.72
UnitedHealth Group
1 Sell rating(s)
4 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
2.81

Summary

UnitedHealth Group beats Alkermes on 10 of the 16 factors compared between the two stocks.

How does UnitedHealth Group compare to Medpace?

Medpace (NASDAQ:MEDP) and UnitedHealth Group (NYSE:UNH) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

UnitedHealth Group has higher revenue and earnings than Medpace. UnitedHealth Group is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medpace$2.53B6.21$451.12M$15.9134.59
UnitedHealth Group$447.57B0.85$12.06B$13.2431.61

Medpace has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market.

Medpace has a net margin of 17.19% compared to UnitedHealth Group's net margin of 2.68%. Medpace's return on equity of 120.89% beat UnitedHealth Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Medpace17.19% 120.89% 24.79%
UnitedHealth Group 2.68%14.65%4.77%

In the previous week, UnitedHealth Group had 57 more articles in the media than Medpace. MarketBeat recorded 57 mentions for UnitedHealth Group and 0 mentions for Medpace. UnitedHealth Group's average media sentiment score of 0.91 beat Medpace's score of 0.00 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company Overall Sentiment
Medpace Neutral
UnitedHealth Group Positive

Medpace presently has a consensus target price of $467.08, indicating a potential downside of 15.14%. UnitedHealth Group has a consensus target price of $411.42, indicating a potential downside of 1.69%. Given UnitedHealth Group's stronger consensus rating and higher possible upside, analysts clearly believe UnitedHealth Group is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medpace
1 Sell rating(s)
10 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.20
UnitedHealth Group
1 Sell rating(s)
4 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
2.81

78.0% of Medpace shares are owned by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are owned by institutional investors. 20.5% of Medpace shares are owned by company insiders. Comparatively, 0.3% of UnitedHealth Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

UnitedHealth Group beats Medpace on 9 of the 17 factors compared between the two stocks.

How does UnitedHealth Group compare to Cigna Group?

UnitedHealth Group (NYSE:UNH) and Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation and profitability.

UnitedHealth Group has a net margin of 2.68% compared to Cigna Group's net margin of 2.26%. Cigna Group's return on equity of 19.75% beat UnitedHealth Group's return on equity.

Company Net Margins Return on Equity Return on Assets
UnitedHealth Group2.68% 14.65% 4.77%
Cigna Group 2.26%19.75%5.30%

In the previous week, UnitedHealth Group had 37 more articles in the media than Cigna Group. MarketBeat recorded 57 mentions for UnitedHealth Group and 20 mentions for Cigna Group. Cigna Group's average media sentiment score of 1.02 beat UnitedHealth Group's score of 0.91 indicating that Cigna Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
UnitedHealth Group
38 Very Positive mention(s)
3 Positive mention(s)
10 Neutral mention(s)
4 Negative mention(s)
2 Very Negative mention(s)
Positive
Cigna Group
12 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

UnitedHealth Group pays an annual dividend of $9.28 per share and has a dividend yield of 2.2%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. UnitedHealth Group pays out 70.1% of its earnings in the form of a dividend. Cigna Group pays out 26.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. UnitedHealth Group has increased its dividend for 15 consecutive years and Cigna Group has increased its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

UnitedHealth Group has higher revenue and earnings than Cigna Group. Cigna Group is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UnitedHealth Group$447.57B0.85$12.06B$13.2431.61
Cigna Group$274.90B0.27$5.96B$23.5911.80

UnitedHealth Group presently has a consensus target price of $411.42, indicating a potential downside of 1.69%. Cigna Group has a consensus target price of $338.30, indicating a potential upside of 21.51%. Given Cigna Group's higher probable upside, analysts clearly believe Cigna Group is more favorable than UnitedHealth Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UnitedHealth Group
1 Sell rating(s)
4 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
2.81
Cigna Group
0 Sell rating(s)
6 Hold rating(s)
15 Buy rating(s)
1 Strong Buy rating(s)
2.77

UnitedHealth Group has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market. Comparatively, Cigna Group has a beta of 0.29, meaning that its share price is 71% less volatile than the broader market.

87.9% of UnitedHealth Group shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 0.3% of UnitedHealth Group shares are owned by insiders. Comparatively, 0.6% of Cigna Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

UnitedHealth Group beats Cigna Group on 11 of the 19 factors compared between the two stocks.

How does UnitedHealth Group compare to Centene?

Centene (NYSE:CNC) and UnitedHealth Group (NYSE:UNH) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

In the previous week, UnitedHealth Group had 49 more articles in the media than Centene. MarketBeat recorded 57 mentions for UnitedHealth Group and 8 mentions for Centene. UnitedHealth Group's average media sentiment score of 0.91 beat Centene's score of -0.07 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Centene
0 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
UnitedHealth Group
38 Very Positive mention(s)
3 Positive mention(s)
10 Neutral mention(s)
4 Negative mention(s)
2 Very Negative mention(s)
Positive

UnitedHealth Group has a net margin of 2.68% compared to Centene's net margin of -3.25%. UnitedHealth Group's return on equity of 14.65% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Centene-3.25% 5.57% 1.54%
UnitedHealth Group 2.68%14.65%4.77%

UnitedHealth Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Centene$194.78B0.17-$6.67B-$13.14N/A
UnitedHealth Group$447.57B0.85$12.06B$13.2431.61

93.6% of Centene shares are held by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are held by institutional investors. 0.4% of Centene shares are held by company insiders. Comparatively, 0.3% of UnitedHealth Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Centene presently has a consensus target price of $60.78, indicating a potential downside of 7.35%. UnitedHealth Group has a consensus target price of $411.42, indicating a potential downside of 1.69%. Given UnitedHealth Group's stronger consensus rating and higher possible upside, analysts clearly believe UnitedHealth Group is more favorable than Centene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene
2 Sell rating(s)
11 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.25
UnitedHealth Group
1 Sell rating(s)
4 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
2.81

Centene has a beta of 1.07, meaning that its stock price is 7% more volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.62, meaning that its stock price is 38% less volatile than the broader market.

Summary

UnitedHealth Group beats Centene on 14 of the 17 factors compared between the two stocks.

How does UnitedHealth Group compare to CVS Health?

CVS Health (NYSE:CVS) and UnitedHealth Group (NYSE:UNH) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment.

CVS Health presently has a consensus target price of $101.28, indicating a potential downside of 2.28%. UnitedHealth Group has a consensus target price of $411.42, indicating a potential downside of 1.69%. Given UnitedHealth Group's higher probable upside, analysts plainly believe UnitedHealth Group is more favorable than CVS Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVS Health
0 Sell rating(s)
4 Hold rating(s)
21 Buy rating(s)
0 Strong Buy rating(s)
2.84
UnitedHealth Group
1 Sell rating(s)
4 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
2.81

80.7% of CVS Health shares are held by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are held by institutional investors. 0.9% of CVS Health shares are held by insiders. Comparatively, 0.3% of UnitedHealth Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

CVS Health has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market.

In the previous week, UnitedHealth Group had 19 more articles in the media than CVS Health. MarketBeat recorded 57 mentions for UnitedHealth Group and 38 mentions for CVS Health. CVS Health's average media sentiment score of 1.18 beat UnitedHealth Group's score of 0.91 indicating that CVS Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVS Health
30 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
UnitedHealth Group
38 Very Positive mention(s)
3 Positive mention(s)
10 Neutral mention(s)
4 Negative mention(s)
2 Very Negative mention(s)
Positive

UnitedHealth Group has a net margin of 2.68% compared to CVS Health's net margin of 0.72%. UnitedHealth Group's return on equity of 14.65% beat CVS Health's return on equity.

Company Net Margins Return on Equity Return on Assets
CVS Health0.72% 11.88% 3.54%
UnitedHealth Group 2.68%14.65%4.77%

UnitedHealth Group has higher revenue and earnings than CVS Health. UnitedHealth Group is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVS Health$402.07B0.33$1.77B$2.2745.66
UnitedHealth Group$447.57B0.85$12.06B$13.2431.61

CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.6%. UnitedHealth Group pays an annual dividend of $9.28 per share and has a dividend yield of 2.2%. CVS Health pays out 117.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. UnitedHealth Group pays out 70.1% of its earnings in the form of a dividend. CVS Health has raised its dividend for 4 consecutive years and UnitedHealth Group has raised its dividend for 15 consecutive years.

Summary

UnitedHealth Group beats CVS Health on 14 of the 19 factors compared between the two stocks.

Get UnitedHealth Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for UNH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UNH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UNH vs. The Competition

MetricUnitedHealth GroupMED IndustryMedical SectorNYSE Exchange
Market Cap$379.59B$54.76B$6.87B$23.59B
Dividend Yield2.18%1.69%2.66%3.98%
P/E Ratio31.5725.9127.7431.87
Price / Sales0.850.66528.4722.49
Price / Cash20.0124.7529.6518.69
Price / Book3.792.8711.104.84
Net Income$12.06B$1.46B$3.57B$1.07B
7 Day Performance-0.20%-0.94%2.22%0.82%
1 Month Performance4.46%-2.18%7.13%4.67%
1 Year Performance35.57%7.47%33.77%18.97%

UnitedHealth Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UNH
UnitedHealth Group
4.594 of 5 stars
$418.48
-1.6%
$411.42
-1.7%
+37.6%$379.59B$447.57B31.57390,000
ALKS
Alkermes
1.5981 of 5 stars
$52.83
+4.7%
$47.06
-10.9%
+89.8%$8.81B$1.48B58.702,050
MEDP
Medpace
1.6038 of 5 stars
$519.96
+1.4%
$467.08
-10.2%
+73.4%$14.85B$2.53B32.686,200
CI
Cigna Group
4.7722 of 5 stars
$281.92
+0.9%
$338.30
+20.0%
-10.0%$74.58B$274.90B11.9567,700
CNC
Centene
2.8607 of 5 stars
$64.73
+2.8%
$60.78
-6.1%
+103.7%$31.96B$194.78BN/A61,100

Related Companies and Tools


This page (NYSE:UNH) was last updated on 7/6/2026 by MarketBeat.com Staff.
From Our Partners